Dana-Farber Researcher Selected to Join the Pew Scholars Program - Top-Institutions - MDSpire

Dana-Farber Researcher Selected to Join the Pew Scholars Program

The Pew Charitable Trusts announced that Xin Gu, PhD, of Dana-Farber Cancer Institute, is among 21 researchers who have been selected to join the Pew Scholars Program in the Biomedical Sciences.

  • By

  • June 18, 2026

  • 2 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    University of California, Berkeley
    University of California, Berkeley

    Berkeley, CA

    Key Differentiators

    • Oncology

  • #4

    Yale School of Medicine
    Yale School of Medicine

    New Haven, CT

    Key Differentiators

    • Oncology

  • #5

    The University of Texas Southwestern Medical Center
    The University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Oncology

Original Source(s)

Dana-Farber Researcher Selected to Join the Pew Scholars Program

  • by

  • June 18, 2026

Related Content

2026 AACR Renal Cell Carcinoma Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the renal cell carcinoma clinical updates you need to know from AACR 2026.

  • June 17, 2026

  • 1 min
ASCO26: Julia Rotow, MD, Silevertinib in Lung Cancer

Dana-Farber Cancer Institute's Dr. Julia Rotow reported on a study looking at silevertinib, with data showing it may offer a new first-line option for hard-to-treat EGFR non-small cell lung cancer variants, with encouraging brain activity and manageable side effects.

  • July 1, 2026

  • 1 min
Case Study: BRCA Mutation Led To Early Detection of Pre-Ovarian Cancer Condition

A 59-year-old woman was referred to Nicole Gaulin, MD, a gynecologic oncologist at Roswell Park Comprehensive Cancer Center, after learning she had a BRCA2 mutation linked with both breast cancer in a cousin and colon cancer in her father.

  • June 24, 2026

  • 1 min